Zacks Investment Research Downgrades HB Fuller (NYSE:FUL) to Sell

Share on StockTwits

HB Fuller (NYSE:FUL) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, Zacks.com reports.

According to Zacks, “H.B. Fuller has been a leading global adhesives provider focusing on perfecting adhesives, sealants and other specialty chemical products to improve products and lives. H.B. Fuller’s commitment to innovation brings together people, products and processes that answer and solve some of the world’s biggest challenges. H.B. Fuller adhesives products used in manufacturing common consumer and industrial goods, including food and beverage containers, disposable diapers, windows, doors, flooring, appliances, sportswear, footwear, multi-wall bags, water filtration products, insulation, textiles, automotives, solar energy systems and electronics. H.B. Fuller also provides customers with technical support and unique solutions designed to address their specific needs. H.B. Fuller has established a variety of product offerings for residential construction markets, such as tile-setting adhesives, grout, sealants and related products. “

A number of other research firms also recently commented on FUL. TheStreet downgraded HB Fuller from a “b-” rating to a “c+” rating in a research note on Tuesday, June 4th. ValuEngine cut shares of HB Fuller from a “hold” rating to a “sell” rating in a report on Monday, May 20th. Finally, JPMorgan Chase & Co. cut shares of HB Fuller from an “overweight” rating to a “neutral” rating and set a $50.79 target price on the stock. in a report on Tuesday, April 9th. They noted that the move was a valuation call. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. HB Fuller presently has a consensus rating of “Hold” and a consensus price target of $57.97.

NYSE:FUL opened at $44.93 on Tuesday. The firm has a market capitalization of $2.28 billion, a P/E ratio of 14.98, a price-to-earnings-growth ratio of 1.14 and a beta of 1.52. HB Fuller has a one year low of $39.22 and a one year high of $59.58. The stock has a 50-day moving average price of $43.46. The company has a quick ratio of 1.36, a current ratio of 2.10 and a debt-to-equity ratio of 1.83.

HB Fuller (NYSE:FUL) last posted its quarterly earnings results on Wednesday, June 26th. The specialty chemicals company reported $0.88 EPS for the quarter, missing the Zacks’ consensus estimate of $0.89 by ($0.01). The firm had revenue of $759.60 million during the quarter, compared to analyst estimates of $779.07 million. HB Fuller had a return on equity of 13.53% and a net margin of 4.52%. The firm’s revenue for the quarter was down 3.8% on a year-over-year basis. During the same quarter last year, the business posted $0.89 earnings per share. As a group, analysts expect that HB Fuller will post 3.29 earnings per share for the current fiscal year.

In other HB Fuller news, VP Heather Campe sold 11,457 shares of the firm’s stock in a transaction dated Friday, April 5th. The shares were sold at an average price of $50.36, for a total value of $576,974.52. Following the transaction, the vice president now owns 20,644 shares of the company’s stock, valued at $1,039,631.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 3.46% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the business. Zions Bancorporation N.A. bought a new position in HB Fuller in the first quarter worth about $187,000. Gotham Asset Management LLC bought a new position in HB Fuller in the fourth quarter worth about $4,437,000. Great West Life Assurance Co. Can raised its holdings in shares of HB Fuller by 1.8% during the first quarter. Great West Life Assurance Co. Can now owns 69,730 shares of the specialty chemicals company’s stock valued at $3,390,000 after buying an additional 1,228 shares during the last quarter. Crawford Investment Counsel Inc. raised its holdings in shares of HB Fuller by 11.1% during the first quarter. Crawford Investment Counsel Inc. now owns 71,854 shares of the specialty chemicals company’s stock valued at $3,495,000 after buying an additional 7,200 shares during the last quarter. Finally, Rhumbline Advisers raised its holdings in shares of HB Fuller by 2.0% during the first quarter. Rhumbline Advisers now owns 160,850 shares of the specialty chemicals company’s stock valued at $7,824,000 after buying an additional 3,146 shares during the last quarter. 98.92% of the stock is currently owned by hedge funds and other institutional investors.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Featured Story: How Important is Technical Analysis of Stocks

Get a free copy of the Zacks research report on HB Fuller (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.